Sunday, September 14, 2025
HomeIndustriesHealthcare

Healthcare

Smiths Medical Issues Urgent Medical Device Correction Letter Notifying Customers

Smiths Medical issued an Urgent Medical Device Correction Letter to notify affected customers of two potential issues with CADDTM Infusion System Infusion Sets related...

Karyopharm Announces Presentation of Updated Phase 1 Selinexor Data in Patients

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced updated results from the Phase 1 portion of its study evaluating the...

Pennsylvania-based Highmark Inc. Joins Theranica’s Coverage with Evidence Program

Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, announced that Highmark Inc. (Highmark), one of America's...

Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy

Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, announced...

Body of Evidence Grows From ZUMA-7 Study Supporting Initial Treatment

Kite, a Gilead Company announced findings from two new analyses of the landmark ZUMA-7 trial of Yescarta, the largest and longest follow-up of a...
0FansLike
0FollowersFollow
spot_img

Hot Topics